Chronic kidney disease screening and renoprotection in type 2 diabetes.
BACKGROUND
Type 2 diabetes (T2D) is a major cause of chronic kidney disease. Control of hypertension and the use of angiotensin converting enzyme inhibitors (ACEI) and/or angiotensin II receptor blockers especially in those with proteinuria have been shown to protect against chronic kidney disease and delay its progression to kidney failure.


METHODS
We reviewed the medical records of 169 patients at 12 months with a view of auditing the screening for chronic kidney disease and the use of renoprotective measures.


RESULTS
Urinalysis was done in 49.1% and serum creatinine in 50.3%. No patient had glomerular filtration rate estimated. Seventy nine (67.6%) of the hypertensive patients were on anti-hypertensives. ACEI was used in 49 (45.8%) of these patients BP control was optimal in 29.1%.


CONCLUSIONS
There is poor adherence to guidelines on chronic kidney disease screening and renoprotection in T2D.
Agaba
E I
EI
Renal Unit, Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria. eiagaba@unijos.edu
Puepet
F H
FH
Ugoya
S O
SO
Agaba
P A
PA
Adabe
R
R
Duguru
M
M
Rowland
A I
AI
D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D054869:Clinical Audit / Q000379:methods*; D003404:Creatinine / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D018450:Disease Progression; D005260:Female; D019983:Guideline Adherence; D006784:Hospitals, Teaching; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D017410:Practice Guidelines as Topic; D011507:Proteinuria / Q000503:physiopathology; D016482:Urinalysis / Q000379:methods
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D003404:Creatinine